Distribution · GCC · Announced 22 Oct 2026
Mubadala Bio → Arabian Ethicals
Distribution deal between Mubadala Bio (United Arab Emirates) and Arabian Ethicals (United Arab Emirates), announced 22 Oct 2026.
Parties: Mubadala Bio (United Arab Emirates) → Arabian Ethicals (United Arab Emirates)
- Deal type
- Distribution
- Value
- Not stated
- Territory
- United Arab Emirates
- Therapeutic area
- Multi-therapy
- Asset
- Commercialization and distribution of Mubadala Bio's specialty medicines in the UAE — combining local manufacturing with commercial and distribution expertise
- Announced
- 22 Oct 2026
Our analysis
Why this matters
Mubadala Bio has now appointed its second private champion in three days — and the roster is clearly being designed, not improvised.
Monday: Modern Pharmaceutical for oncology and immunology . Today: Arabian Ethicals, a 49-year Ghobash Group distributor with a proven specialty playbook — it has run Accord Healthcare's oncology portfolio in the UAE since December 2025 — to expand access to Mubadala Bio's specialty medicines.
The full analysis is free to read with a work email on this page.
Source: Mubadala Bio announcement